Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, an oral medication used to treat type 2 diabetes. It works by increasing the amount of insulin that the body produces after meals, when blood sugar is elevated.
Brand name: Onglyza
-
Drugs.com: Onglyza
Offers description, indications, risks, warnings, precautions, restrictions, side effects, and interactions.
-
MedlinePlus: Saxagliptin
Reviews indications, proper usage, precautions, missed dose, side effects, and warnings.
-
New Type 2 Diabetes Drug Onglyza Approved
Information from WebMD provides the news release explaining uses, related medications, mechanism, and side effects.
-
Onglyza™ (saxagliptin)
Provides details on once-daily oral prescription medicine used along with diet and exercise to control blood sugar for type 2 diabetes.
-
PubMed Health: Saxagliptin
Includes purpose, dosing, precautions, dietary instructions, warnings, missed dose, side effects, and interactions.
-
RxList: Onglyza (Saxagliptin)
Contains description, indications, dosage, side effects, interactions, warnings, precautions, and pharmacology.